diabetestalk.net

The Global Diabetes Epidemic, Brought To You By Global Development

The Global Diabetes Epidemic, Brought to You by Global Development

The Global Diabetes Epidemic, Brought to You by Global Development

The link between economic growth and the worldwide diabetes epidemic, explained
Diners in Shanghai eat at a Kentucky Fried Chicken outlet. (Aly Song/Reuters)
As globalization exports our culture across the world, it also spreads our health problems. For much of the 20th century, a person's likelihood to develop type-2 diabetes depended as much on the wealth of their nation as their biology. Those living in the developed world survived to old age and eventually succumbed to "diseases of affluence": cancer, cardiovascular disease, and diabetes. In contrast, undernourishment, violence, and communicable diseases ravaged the health of residents of developing countries.
And this is the way things remain in the developed world: even in poor parts of the United States, almost no one dies of tuberculosis. But in low- and middle-income countries, the distinction fades. The "diseases of affluence" have embedded themselves in communities anything but affluent. Now, cholera strikes next door to cancer; the malnourished and diabetic share a roof.
In this new landscape of health in the developing world, the impact of diabetes is momentous. Since 1980, the number of diabetics worldwide has ballooned from 152 million to between 285 and 347 million today. Of these, three-quarters live in the developing world, where diabetes afflicts more than six times as many people as HIV. Why, if infectious diseases persist and life expectancies remain low, has diabetes taken such a toll on the health of the impoverished?
One explanation relies on a trio of social forces: aging population, urbanization, a Continue reading

Rate this article
Total 1 ratings
Reversing Type 2 Diabetes with Nutritional Ketosis

Reversing Type 2 Diabetes with Nutritional Ketosis

Virta is a science-based online specialty medical clinic using continuous remote monitoring and intensive coaching to help our patients reverse type 2 diabetes and prediabetes. A unique contributor to our success in this is harnessing and sustaining the metabolic benefits of nutritional ketosis. Admittedly, reversing diabetes is a rather bold goal. By way of contrast, the American Diabetes Association defines type 2 diabetes as a progressive disease whose course at best can be slowed by lifestyle change and medication. Based upon solid science—some old and some new—we beg to differ. Perhaps it’s time for a paradigm change.
There are few times in the lives of medical scientists where we have the opportunity to change the course of a major medical disease; and even fewer cases where we actually succeed in doing so.
In 1920, Banting’s discovery that injected insulin could control type 1 diabetes (T1D) was such an event. As a result, over the last century, millions of people with T1D have achieved long and productive lives; whereas before 1920 most of them would have succumbed to this insulin-deficiency disease within less than a year.
Type 2 diabetes (T2D), on the other hand, is a very different disease that affects hundreds of millions of people. It responds very poorly to injected insulin. Whereas T1D patients cannot make insulin, people with T2D typically make lots of insulin but are resistant to insulin’s effects across a variety of cellular functions. Despite these facts having been known for 5 decades, we are taught that the core components of T2D management ar Continue reading

Diabetes Type 3c?

Diabetes Type 3c?

Little-known diabetes type—caused by pancreas-related problems—is often misdiagnosed and mistreated a new UK study finds
It’s not Type 1…and it’s not Type 2. When researchers from the UK’s University of Surrey checked the health records of 2.3 million adults for a new study published in the November issue of Diabetes Care, they uncovered more cases than expected of a little-known blood sugar problem: Diabetes type 3c. And most were misdiagnosed, meaning people with “3c” may not have gotten the best treatment.
Type 3c is “diabetes that acts differently,” according to study co-author Andrew McGovern, a research fellow at the University of Exeter and honorary clinical researcher at the University of Surrey. It’s caused by damage to the pancreas—the gland that contains insulin-producing islet cells—from inflammation (pancreatitis), surgery or cancer. The damage knocks out some, but not all, islet cells, reducing insulin levels in the body. In contrast, type 1 diabetes is triggered by an immune-system attack that knocks out virtually all of a person’s islet cells and type 2 happens when the pancreas can’t make enough insulin to overcome insulin resistance.
The study looked at new cases of diabetes. It found 559 people with probable type 3c. It was more common than new type 1 diabetes in adults (354 had that type), which surprised the researchers. More concerning: 88% with type 3c were misdiagnosed as type 2s. That’s a problem, because conventional type 2 drugs that boost insulin sensitivity and insulin production may not work well for 3cs. They we Continue reading

Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study

Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study

Summary
Previous studies have not adequately captured the heterogeneous nature of the diabetes epidemic in India. The aim of the ongoing national Indian Council of Medical Research–INdia DIABetes study is to estimate the national prevalence of diabetes and prediabetes in India by estimating the prevalence by state.
We used a stratified multistage design to obtain a community-based sample of 57 117 individuals aged 20 years or older. The sample population represented 14 of India's 28 states (eight from the mainland and six from the northeast of the country) and one union territory. States were sampled in a phased manner: phase I included Tamil Nadu, Chandigarh, Jharkhand, and Maharashtra, sampled between Nov 17, 2008, and April 16, 2010; phase II included Andhra Pradesh, Bihar, Gujarat, Karnataka, and Punjab, sampled between Sept 24, 2012, and July 26, 2013; and the northeastern phase included Assam, Mizoram, Arunachal Pradesh, Tripura, Manipur, and Meghalaya, with sampling done between Jan 5, 2012, and July 3, 2015. Capillary oral glucose tolerance tests were used to diagnose diabetes and prediabetes in accordance with WHO criteria. Our methods did not allow us to differentiate between type 1 and type 2 diabetes. The prevalence of diabetes in different states was assessed in relation to socioeconomic status (SES) of individuals and the per-capita gross domestic product (GDP) of each state. We used multiple logistic regression analysis to examine the association of various factors with the prevalence of diabetes and prediabetes.
The overall prevalence of diabetes in all 15 Continue reading

2017 Diabetes Facts & Statistics

2017 Diabetes Facts & Statistics

Diabetes costs the U.S. economy over $245 billion per year, making it the country’s most expensive disease. But the damage obviously extends well beyond dollars and cents. It’s the 3rd most deadly disease in the U.S., claiming over 80,000 lives per year and becoming a daily concern for millions more.
Yet the roughly 9 in 10 Americans who don’t have diabetes probably don’t understand the full extent of the struggle, either. The same can also be said of the nearly 1 in 4 people with diabetes who don’t know they have it.
So to help spread awareness, WalletHub assembled an interesting infographic exploring the impact of the disease as well as what folks are doing to fight back. We also surveyed a panel of diabetes experts about issues ranging from personal finance to policy. You can find everything below.
Ask The Experts: Dealing With & Defeating Diabetes
For insights into how we can reduce the many costs of diabetes, WalletHub posed the following questions to a panel of experts. You can check out their bios and responses below.
What are the warning signs that someone may have Type 1 Diabetes? What about Type 2?
What steps can someone take today to help reduce diabetes risk?
What should public officials do to raise awareness about diabetes and the need for screening?
What are some common myths or misunderstandings people have about diabetes?
How have individuals with diabetes fared under the Affordable Care Act?
What tips do you have for a person with Type 2 diabetes looking to maintain a healthy and active lifestyle while on a budget? Continue reading

No more pages to load

Popular Articles

  • 'Diabetes epidemic in Indigenous populations' highlights disparity

    About eight in 10 Indigenous Canadians who are young adults will develop Type 2 diabetes in their lifetimes compared with five in 10 in the general population, a new study suggests. To make the projection published in Monday's issue of the Canadian Medical Association Journal, researchers in Alberta used data on a population of 2.8 million adults who were free of diabetes in the province and follo ...

  • Fighting the diabetes epidemic the way public health has fought HIV

    In the U.S. and other high-income countries, diabetes is a good news, bad news scenario. On one hand, people who have diabetes today fare better than they did 20 years ago. They are living longer and suffering fewer complications, such as heart disease, kidney disease, amputations, strokes, and blindness. SEEBRI NEOHALER should not be initiated in patients with acutely deteriorating or potentially ...

  • Diabetes: Fighting the epidemic the way public health has fought HIV

    In the U.S. and other high-income countries, diabetes is a good news, bad news scenario. On one hand, people who have diabetes today fare better than they did 20 years ago. They are living longer and suffering fewer complications, such as heart disease, kidney disease, amputations, strokes, and blindness. On the other hand, more people are developing diabetes than experts even projected, with some ...

  • 'They Never Talked To Me Like A Real Person': Fighting a Diabetes Epidemic With Empathy

    Tap here to turn on desktop notifications to get the news sent straight to you. 11/15/2017 09:53 am ETUpdatedDec 22, 2017 'They Never Talked To Me Like A Real Person': Fighting a Diabetes Epidemic With Empathy Houston is tapping into faith communities to tackle soaring diabetes rates. Marguerite Butler (left)has worked with nutritionist Joy Ashby Cornthwaite (right), who has helped her under ...

  • Treating Diabetes: Practical Advice for Combatting a Modern Epidemic

    > Treating Diabetes: Practical Advice for Combatting a Modern Epidemic Treating Diabetes: Practical Advice for Combatting a Modern Epidemic Adapted from The Fourfold Path to Healing by Tom Cowan, MD, with Sally Fallon and Jaimen McMillan, to be published Spring 2004, NewTrends Publishing. Diabetes is so common in America and other western countries that its presence in any human group has bec ...

  • Dentists at the Front Line in Diabetes Epidemic

    HealthDay Reporter THURSDAY, Feb. 23, 2017 (HealthDay News) -- You'd probably be surprised if your dentist said you might have type 2 diabetes. But new research finds that severe gum disease may be a sign the illness is present and undiagnosed. The study found that nearly one in five people with severe gum disease (periodontitis) had type 2 diabetes and didn't know it. The researchers said these f ...

  • WHO | Addressing Asias fast growing diabetes epidemic

    Addressing Asias fast growing diabetes epidemic Hampered by shortages of resources, specialized services and skilled health workers, India and other countries in south-east Asia are scrambling to respond to type 2 diabetes epidemics. Sophie Cousins reports. Bulletin of the World Health Organization 2017;95:550-551. doi: http://dx.doi.org/10.2471/BLT.17.020817 A diabetes nutrition counselling ...

  • India’s Diabetes Epidemic Shifts to Poorer People in More Affluent Cities

    The Indian Council of Medical Research – India Diabetes (ICMR-INDIAB) study is the largest nationally representative study of diabetes in India and includes data from 57000 people across 15 states. As part of the study, each person had their body weight, height, waist circumference and blood pressure measured. Glucose tolerance tests were used to diagnose diabetes and pre-diabetes. The prevalenc ...

  • Women in India with Gestational Diabetes Mellitus Strategy (WINGS): Methodology and development of model of care for gestational diabetes mellitus (WINGS 4)

    Women in India with Gestational Diabetes Mellitus Strategy (WINGS): Methodology and development of model of care for gestational diabetes mellitus (WINGS 4) Find articles by Manni Mohanraj Mahalakshmi Department of Policy and Programmes, International Diabetes Federation, Brussels, Belgium 1Department of Epidemiology, Madras Diabetes Research Foundation, Chennai, Tamil Nadu, India 2Departmen ...

Related Articles